Leoš Pleva

1.2k total citations
18 papers, 181 citations indexed

About

Leoš Pleva is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Leoš Pleva has authored 18 papers receiving a total of 181 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Surgery, 7 papers in Cardiology and Cardiovascular Medicine and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Leoš Pleva's work include Coronary Interventions and Diagnostics (12 papers), Cardiac Imaging and Diagnostics (5 papers) and Cerebrovascular and Carotid Artery Diseases (4 papers). Leoš Pleva is often cited by papers focused on Coronary Interventions and Diagnostics (12 papers), Cardiac Imaging and Diagnostics (5 papers) and Cerebrovascular and Carotid Artery Diseases (4 papers). Leoš Pleva collaborates with scholars based in Czechia, Netherlands and Germany. Leoš Pleva's co-authors include Pavel Kukla, Ota Hlinomaz, Pavlína Kušnierová, Jana Zapletalová, Pavlína Plevová, Jana Zapletalová, Michal Karpíšek, Zdeněk Švagera, Václav Procházka and Miroslav Homza and has published in prestigious journals such as Journal of the American College of Cardiology, European Heart Journal and Scandinavian Journal of Clinical and Laboratory Investigation.

In The Last Decade

Leoš Pleva

16 papers receiving 173 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leoš Pleva Czechia 6 135 77 63 55 13 18 181
Pavel Kukla Czechia 7 137 1.0× 94 1.2× 68 1.1× 58 1.1× 12 0.9× 21 192
Keisuke Yasumura United States 8 223 1.7× 135 1.8× 97 1.5× 116 2.1× 14 1.1× 32 305
Steven D. Filardo United States 6 190 1.4× 176 2.3× 69 1.1× 184 3.3× 5 0.4× 8 318
Maxime Tapponnier Switzerland 7 168 1.2× 137 1.8× 83 1.3× 23 0.4× 3 0.2× 14 269
Eline H. Ploumen Netherlands 9 209 1.5× 169 2.2× 71 1.1× 83 1.5× 52 4.0× 31 293
Fusako Oshima Japan 2 363 2.7× 251 3.3× 142 2.3× 93 1.7× 9 0.7× 2 389
Levente Tóth Hungary 9 68 0.5× 65 0.8× 28 0.4× 75 1.4× 9 0.7× 26 248
Jiapeng Chu China 9 69 0.5× 88 1.1× 34 0.5× 56 1.0× 28 2.2× 16 221
Takuya Nakahashi Japan 9 148 1.1× 144 1.9× 65 1.0× 45 0.8× 30 2.3× 25 253
Martijn Scholte Netherlands 10 367 2.7× 299 3.9× 98 1.6× 56 1.0× 3 0.2× 15 411

Countries citing papers authored by Leoš Pleva

Since Specialization
Citations

This map shows the geographic impact of Leoš Pleva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leoš Pleva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leoš Pleva more than expected).

Fields of papers citing papers by Leoš Pleva

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leoš Pleva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leoš Pleva. The network helps show where Leoš Pleva may publish in the future.

Co-authorship network of co-authors of Leoš Pleva

This figure shows the co-authorship network connecting the top 25 collaborators of Leoš Pleva. A scholar is included among the top collaborators of Leoš Pleva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leoš Pleva. Leoš Pleva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Pleva, Leoš, Pavel Kukla, Tomáš Kovárník, & Jana Zapletalová. (2025). Comparing the Efficacy of Sirolimus and Paclitaxel-Eluting Balloon Catheters in the Treatment of Coronary In-Stent Restenosis: A Prospective Randomized Study (TIS 2 Study). Circulation Cardiovascular Interventions. 18(5). e014677–e014677.
2.
Kukla, Pavel, Tomáš Kovárník, Jana Zapletalová, & Leoš Pleva. (2023). TCT-431 Comparison of the Efficacy of Sirolimus and Paclitaxel-Eluting Balloon Catheters in the Treatment of Coronary In-Stent Restenosis: The TIS-2 Study.. Journal of the American College of Cardiology. 82(17). B173–B174. 1 indexed citations
3.
Káňová, Marcela, et al.. (2021). Administration of Anabolic Steroids in Combination with Vitamin D in the Early Stage of Treatment of Polytrauma Patients - a Dead End?. Acta chirurgiae orthopaedicae et traumatologiae Cechoslovaca. 88(3). 176–183. 1 indexed citations
4.
Pleva, Leoš, Pavel Kukla, Jana Zapletalová, & Ota Hlinomaz. (2021). In-stent restenosis treatment with seal-wing paclitaxel-eluting balloon catheters. Cor et Vasa. 63(4). 442–447.
5.
6.
7.
Pleva, Leoš, Pavel Kukla, Jana Zapletalová, & Ota Hlinomaz. (2018). Long‐term outcomes after treatment of bare‐metal stent restenosis with paclitaxel‐coated balloon catheters or everolimus‐eluting stents: 3‐year follow‐up of the TIS clinical study. Catheterization and Cardiovascular Interventions. 92(6). E416–E424. 9 indexed citations
8.
Pleva, Leoš, Pavel Kukla, & Ota Hlinomaz. (2018). Treatment of coronary in-stent restenosis: a systematic review.. PubMed. 15(2). 173–184. 61 indexed citations
9.
Pleva, Leoš, Pavel Kukla, Jana Zapletalová, & Ota Hlinomaz. (2017). Efficacy of a seal-wing paclitaxel-eluting balloon catheters in the treatment of bare metal stent restenosis. BMC Cardiovascular Disorders. 17(1). 168–168. 3 indexed citations
10.
Pleva, Leoš, Pavlína Kušnierová, Pavlína Plevová, et al.. (2017). The APOE ε2 allele is associated with increased plasma apolipoprotein E levels in patients with coronary artery disease. Cor et Vasa. 59(3). e235–e239. 1 indexed citations
11.
Pleva, Leoš, Pavel Kukla, Pavlína Kušnierová, Jana Zapletalová, & Ota Hlinomaz. (2016). Comparison of the Efficacy of Paclitaxel-Eluting Balloon Catheters and Everolimus-Eluting Stents in the Treatment of Coronary In-Stent Restenosis. Circulation Cardiovascular Interventions. 9(4). e003316–e003316. 63 indexed citations
12.
Kukla, Pavel, Leoš Pleva, Radim Brát, et al.. (2015). Inferior vena cava leiomyosarcoma with right atrium tumorous mass presenting as heart failure in a 70-year-old man: A case report. Cor et Vasa. 58(5). e458–e465. 1 indexed citations
13.
Kušnierová, Pavlína, et al.. (2015). Reference intervals of plasma matrix metalloproteinases 2, 3, and 9 and serum asymmetric dimethylarginine levels. Scandinavian Journal of Clinical and Laboratory Investigation. 75(6). 508–513. 7 indexed citations
14.
Pleva, Leoš, et al.. (2015). The rs1803274 polymorphism of the BCHE gene is associated with an increased risk of coronary in-stent restenosis. BMC Cardiovascular Disorders. 15(1). 135–135. 10 indexed citations
15.
Pleva, Leoš, Pavlína Kušnierová, Pavlína Plevová, et al.. (2015). Increased levels of MMP-3, MMP-9 and MPO represent predictors of in-stent restenosis, while increased levels of ADMA, LCAT, ApoE and ApoD predict bare metal stent patency. Biomedical Papers. 159(4). 586–594. 15 indexed citations
16.
Pleva, Leoš, et al.. (2014). Dedicated Tryton Side Branch Stents used in the treatment of coronary bifurcation lesions. Cor et Vasa. 56(6). e478–e485. 1 indexed citations
17.
Pleva, Leoš, Tomáš Jonszta, & Pavel Kukla. (2013). Percutaneous coronary angioplasty of a bifurcation lesion in the Y saphenous vein graft. Cor et Vasa. 56(5). e382–e387. 1 indexed citations
18.
Pleva, Leoš, et al.. (2009). [Our first experiences with autologous transplantation of bone marrow stem cells to treat pseudarthrosis, delayed fracture healing and long bone defects fracture].. PubMed. 55(3). 187–9. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pavel Kukla Breakdown of academic impact, for papers by Keisuke Yasumura Breakdown of academic impact, for papers by Steven D. Filardo Breakdown of academic impact, for papers by Maxime Tapponnier Breakdown of academic impact, for papers by Eline H. Ploumen Breakdown of academic impact, for papers by Fusako Oshima Breakdown of academic impact, for papers by Levente Tóth Breakdown of academic impact, for papers by Jiapeng Chu Breakdown of academic impact, for papers by Takuya Nakahashi Breakdown of academic impact, for papers by Martijn Scholte
Rankless by CCL
2026